SCHEMBL19639836

SCHEMBL19639836

[N-]=[N+]=Nc1ccc(/C=C2/CCC/C(=C\c3ccc(N=[N+]=[N-])cc3)C2=O)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 6/20 0.56
▸ HSD11B1 P28845 3/20 0.56
▸ F3 P13726 2/20 0.56
▸ CYP2C9 P11712 2/20 0.56
▸ MAPT P10636 3/20 0.51
▸ HTT P42858 2/20 0.51
▸ NPC1 O15118 1/20 0.51
▸ HSP90AA1 P07900 1/20 0.51
▸ XBP1 P17861 1/20 0.51
▸ MAPK1 P28482 1/20 0.51
▸ RAB9A P51151 1/20 0.51
▸ SMN1; SMN2 Q16637 1/20 0.51
▸ HPGD P15428 1/20 0.51
▸ MGAM O43451 2/20 0.50
▸ GAA P10253 2/20 0.50
▸ SI P14410 2/20 0.50
▸ MGAM2 Q2M2H8 2/20 0.50
▸ PTGS2 P35354 1/20 0.50
▸ F2 P00734 4/20 0.49
▸ F10 P00742 3/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23663603 1.00 CYP1A2 (0.56) CYP1A2HSD11B1F3CYP2C9MAPT
SCHEMBL14127105 1.00 CYP1A2 (0.56) CYP1A2HSD11B1F3CYP2C9MAPT
SCHEMBL17203062 0.86 AKR1C3 (0.46) CYP1A2HSD11B1F3CYP2C9MAPT
SCHEMBL17203060 0.86 AKR1C3 (0.46) CYP1A2HSD11B1F3CYP2C9MAPT
SCHEMBL20572299 0.86 AKR1C3 (0.53) CYP1A2HSD11B1F3CYP2C9MAPT
SCHEMBL16500277 0.86 AKR1C3 (0.53) CYP1A2HSD11B1F3CYP2C9MAPT
SCHEMBL14642023 0.84 CYP1A2 (0.56) CYP1A2HSD11B1F3CYP2C9MAPT
SCHEMBL25401542 0.82 DNMT1 (0.39) CYP1A2HSD11B1F3CYP2C9MAPT
SCHEMBL13886925 0.80 MAPT (0.55) CYP1A2HSD11B1CYP2C9MAPTHTT
SCHEMBL13886919 0.80 USP18 (0.54) CYP1A2HSD11B1F3CYP2C9MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250236705-A1 DIVERSITY-ORIENTED POLYMERS OF INTRINSIC MICROPOROSITY AND USES THEREOF U.S. DEPARTMENT OF ENERGY 2025-07-24 — — US disclosed
US-12084544-B2 Diversity-oriented polymers of intrinsic microporosity and uses thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2024-09-10 — — US disclosed
EP-3837038-B1 DIVERSITY-ORIENTED POLYMERS OF INTRINSIC MICROPOROSITY AND USES THEREOF UNIV CALIFORNIA (US) 2023-02-15 — — EP disclosed
US-11329304-B2 Redox-flow batteries employing oligomeric organic active materials and size-selective microporous polymer membranes THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2022-05-10 — — US disclosed
US-20210309802-A1 DIVERSITY-ORIENTED POLYMERS OF INTRINSIC MICROPOROSITY AND USES THEREOF UNITED STATES DEPARTMENT OF ENERGY 2021-10-07 — — US disclosed
EP-3837038-A1 DIVERSITY-ORIENTED POLYMERS OF INTRINSIC MICROPOROSITY AND USES THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2021-06-23 — — EP disclosed
WO-2020037246-A1 DIVERSITY-ORIENTED POLYMERS OF INTRINSIC MICROPOROSITY AND USES THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2020-02-20 — — WO disclosed
US-20170346104-A1 Redox-Flow Batteries Employing Oligomeric Organic Active Materials and Size-Selective Microporous Polymer Membranes THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS 2017-11-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210309802-A1 DIVERSITY-ORIENTED POLYMERS OF INTRINSIC MICROPOROSITY AND USES THEREOF PARN, PARG, PAM CYP1A2 2812/4885HSD11B1 4572/4885F3 2837/4885
US-12084544-B2 Diversity-oriented polymers of intrinsic microporosity and uses thereof PAM, TMPO, ADM2 CYP1A2 3480/4885HSD11B1 4447/4885F3 2286/4885
US-20250236705-A1 DIVERSITY-ORIENTED POLYMERS OF INTRINSIC MICROPOROSITY AND USES THEREOF PAM, TMPO, ADM2 CYP1A2 3480/4885HSD11B1 4447/4885F3 2286/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback